Long COVID: the problem society wants to forget

Long COVID: the problem society wants to forg...

Up next

Everyone Will Feel the $1 Trillion Cut in Medicaid

Medicaid provides health insurance for 1 in 5 Americans and plays a crucial role in US health care infrastructure. The One Big Beautiful Bill Act (OBBBA) is estimated to cut Medicaid spending by nearly $1 trillion by 2034 and cause millions of enrollees to lose coverage. In this ...  Show more

Should Everyone be on GLP-1s?

GLP-1 receptor agonists are one of the most revolutionary new classes of drugs in decades. In this episode of Healthy Dialogue, host Derek C. Angus, MD, MPH, sat down with Jens Juul Holst, MD, DMSc, and Lotte Bjerre Knudsen, DMSc, 2 pioneering scientists behind the discovery and ...  Show more

Recommended Episodes

Randomized Trial of Anti-VEGF to Prevent Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME)
JAMA Ophthalmology Author Interviews

Interview with Raj K Maturi, MD, and Jennifer K Sun, MD, authors of Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial and with Howa ...  Show more

November 2021: Issue Summary 1
Radiology Podcast | RSNA

Dr. Lauren Kim interviews Dr. Florian Gassert and Dr. Theresa Urban. X-ray Dark-Field Chest Imaging: Qualitative and Quantitative Results in Healthy Humans. Gassert and Urban et al. Radiology 2021; 301:389–395. Introduction by Dr. Linda Chu 

USPSTF Recommendation: Interventions for High BMI in Children and Adolescents
JAMA Clinical Reviews

Interview with John M. Ruiz, PhD, USPSTF member and coauthor of Management of BMI in Children: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.

Related Content:

< ...  Show more

Time to Significant Benefit of Finerenone in Patients with Heart Failure | HFSA 2024
JACC This Week

Michelle M Kittleson, MD, FACC, JACC Associate Editor, speaks with author Muthiah Vaduganathan, MD on his accepted paper concerning the FINEARTS trial published in JACC.